TSLA's original thesis remains intact, supported by improving technical momentum and sector alignment. The stock is trading above its entry price and stop level, with the nearest resistance at $337.24 aligning with the original target. Rising RSI and MACD, along with a bullish zero-cross, confirm that the uptrend is valid and the position is progressing toward its target. The broader market regime is bullish, and TSLA is participating in sector strength, further supporting the hold case.
The original long thesis remains intact: TSLA found support near the 52-week low ($297.38) after the post-earnings flush, and is now on a three-day winning streak with improving momentum (4h MACD bullish zero-cross, RSI rising from oversold). The Norway registration collapse trigger is noise from a ~2% market, and the stock is shrugging it off. With the stop at $301 providing a defined risk floor and the target at $337 still achievable within the remaining horizon, the position should be held.
The position is +1.6% and progressing, with 4h momentum turning up (bullish MACD zero-cross, RSI rising to 37.5) and a 3-day win streak off the $297 low that shrugged off the NHTSA inquiry and Norway registration collapse. XLY sector breadth confirms the move, the bullish equity regime is supportive, and price sits comfortably above the $301 stop with a feasible ~5.6% run to the $337 target within the remaining 12-day horizon. No structural invalidation has occurred, so the original long thesis remains intact.
No model argued for EXIT.
The position is +1.6% and progressing, with 4h momentum turning up (bullish MACD zero-cross, RSI rising to 37.5) and a 3-day win streak off the $297 low that shrugged off the NHTSA inquiry and Norway registration collapse. XLY sector breadth confirms the move, the bullish equity regime is supportive, and price sits comfortably above the $301 stop with a feasible ~5.6% run to the $337 target within the remaining 12-day horizon. No structural invalidation has occurred, so the original long thesis remains intact.
The position is +1.6% and progressing, with 4h momentum turning up (bullish MACD zero-cross, RSI rising to 37.5) and a 3-day win streak off the $297 low that shrugged off the NHTSA inquiry and Norway registration collapse. XLY sector breadth confirms the move, the bullish equity regime is supportive, and price sits comfortably above the $301 stop with a feasible ~5.6% run to the $337 target within the remaining 12-day horizon. No structural invalidation has occurred, so the original long thesis remains intact.
▼ Click to expandTSLA remains deeply below its SMA20/SMA50 on the daily (-11% and -18%), Q2 EPS badly missed (0.33 vs 0.54 est), capex guidance rose above $25B, and the Norway registration collapse plus NHTSA inquiry point to demand and regulatory deterioration. Volume is depressed (6th percentile), the target sits at unbroken resistance, and rich valuation (P/E 285) offers little fundamental cushion if the bounce fails.
▼ Click to expandThe original long thesis remains intact: TSLA found support near the 52-week low ($297.38) after the post-earnings flush, and is now on a three-day winning streak with improving momentum (4h MACD bullish zero-cross, RSI rising from oversold). The Norway registration collapse trigger is noise from a ~2% market, and the stock is shrugging it off. With the stop at $301 providing a defined risk floor and the target at $337 still achievable within the remaining horizon, the position should be held.
The original long thesis remains intact: TSLA found support near the 52-week low ($297.38) after the post-earnings flush, and is now on a three-day winning streak with improving momentum (4h MACD bullish zero-cross, RSI rising from oversold). The Norway registration collapse trigger is noise from a ~2% market, and the stock is shrugging it off. With the stop at $301 providing a defined risk floor and the target at $337 still achievable within the remaining horizon, the position should be held.
▼ Click to expandThe post-earnings damage was severe (EPS miss of 39%, -14% drop), and the recovery remains tentative with price still below both the 4h and 1d SMA20. The Norway registration collapse, while a small market, signals potential broader European demand weakness. Volume is depressed (6th percentile), suggesting the recovery lacks conviction. If the 4h SMA20 at $326.53 rejects price, the risk/reward deteriorates with only $18 to target but $17.89 to stop from current levels.
▼ Click to expandTSLA's original thesis remains intact, supported by improving technical momentum and sector alignment. The stock is trading above its entry price and stop level, with the nearest resistance at $337.24 aligning with the original target. Rising RSI and MACD, along with a bullish zero-cross, confirm that the uptrend is valid and the position is progressing toward its target. The broader market regime is bullish, and TSLA is participating in sector strength, further supporting the hold case.
TSLA's original thesis remains intact, supported by improving technical momentum and sector alignment. The stock is trading above its entry price and stop level, with the nearest resistance at $337.24 aligning with the original target. Rising RSI and MACD, along with a bullish zero-cross, confirm that the uptrend is valid and the position is progressing toward its target. The broader market regime is bullish, and TSLA is participating in sector strength, further supporting the hold case.
▼ Click to expandThe exit case would be triggered if TSLA breaks below the 4-hour support level of $297.38, invalidating the original thesis and confirming a failed retest of support. Additionally, if the broader market regime shifts to bearish or TSLA fails to participate in sector strength, the risk/reward profile would deteriorate, justifying an exit. However, neither condition is currently active.
▼ Click to expandIntraday discovery triggered reanalysis on TSLA. Verdict: HOLD (0/3 EXIT). Conviction: 91.